Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Straumann

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Allergy|July 17, 2017
Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitisD Simon, B Page, M Vogel, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2015
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's diseaseE Safroneeva, S R Vavricka, N Fournier, et al.
Alimentary Pharmacology & Therapeutics|July 8, 2015
Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patientsE Safroneeva, S Vavricka, N Fournier, et al.
Allergy|August 26, 2015
Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based studyB Giriens, P Yan, E Safroneeva, et al.
Allergy|March 13, 2016
A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE familiesA Straumann, C Blanchard, S Radonjic-Hoesli, et al.
Allergy|June 5, 2014
Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitisT Kuchen, A Straumann, E Safroneeva, et al.
Revue Medicale Suisse|August 25, 2006
[Infliximab--practical guidelines for the treatment of Crohn's disease]P Bauerfeind, C Beglinger, J Beltinger, et al.
Scandinavian Journal of Gastroenterology|April 1, 1988
Reduction in early recurrence of variceal bleeding by propranololU A Marbet, A Straumann, K E Gyr, et al.
Allergy|February 9, 2012
Pediatric and adult eosinophilic esophagitis: similarities and differencesA Straumann, S S Aceves, C Blanchard, et al.
Allergy|February 6, 2013
Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisA Straumann, S Hoesli, Ch Bussmann, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Allergy|July 17, 2017
Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitisD Simon, B Page, M Vogel, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2015
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's diseaseE Safroneeva, S R Vavricka, N Fournier, et al.
Alimentary Pharmacology & Therapeutics|July 8, 2015
Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patientsE Safroneeva, S Vavricka, N Fournier, et al.
Allergy|August 26, 2015
Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based studyB Giriens, P Yan, E Safroneeva, et al.
Allergy|March 13, 2016
A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE familiesA Straumann, C Blanchard, S Radonjic-Hoesli, et al.
Allergy|June 5, 2014
Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitisT Kuchen, A Straumann, E Safroneeva, et al.
Revue Medicale Suisse|August 25, 2006
[Infliximab--practical guidelines for the treatment of Crohn's disease]P Bauerfeind, C Beglinger, J Beltinger, et al.
Scandinavian Journal of Gastroenterology|April 1, 1988
Reduction in early recurrence of variceal bleeding by propranololU A Marbet, A Straumann, K E Gyr, et al.
Allergy|February 9, 2012
Pediatric and adult eosinophilic esophagitis: similarities and differencesA Straumann, S S Aceves, C Blanchard, et al.
Allergy|February 6, 2013
Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisA Straumann, S Hoesli, Ch Bussmann, et al.
Pageof 5